Human embryo genetic editing: hope or pipe dream?

strict warning: Declaration of views_plugin_style_default::options() should be compatible with views_object::options() in /home/tcmlorne/public_html/modules/views/plugins/views_plugin_style_default.inc on line 0.

Like many other technological developments in reproductive medicine, human embryo genetic editing has generated considerable hope and excitement, although it has also provoked great apprehension. The excitement and hope rooted in this technology are understandable. Genome editing tools, such as CRISPR-Cas9, promise to transform biomedical research and clinical care. The Nobel Prize awarded in 2020 to its developers, Emmanuelle Charpentier and Jennifer Doudna, recognized the groundbreaking nature of this genomic tool (1).